Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BGNE | INCY | GMAB | ||
| Company | Beigene Ltd ADR | Incyte Corp | Genmab A/S ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 184.00 | 94.50 | 26.66 | ||
| High | 187.42 | 97.66 | 27.06 | ||
| Low | 183.91 | 94.50 | 26.63 | ||
| Latest | 184.71 | 96.25 | 26.78 | ||
| Change | +0.90 | +1.60 | -0.09 | ||
| % Change | +0.49% | +1.69% | -0.33% | ||
| Volume | 331,600 | 550,450 | 317,692 | ||
| 20-Day Average Volume | 387,225 | 1,245,808 | 1,522,448 | ||
| Previous Close | 183.81 | 94.65 | 26.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 186.42 | 95.63 | 27.73 | ||
| 20-Day Raw Stochastic | 34.29% | 69.09% | 30.65% | ||
| 20-Day Relative Strength | 45.13 | 51.70 | 44.08 | ||
| Weighted Alpha | +11.14 | +43.22 | +15.15 | ||
| Today's Opinion | 24% Sell | 8% Buy | 56% Sell | ||
| Previous Opinion | 24% Sell | 24% Sell | 72% Sell | ||
| Last Month's Opinion | 80% Buy | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.94% since 12/23/24 | -0.04% since 04/20/26 | -3.67% since 04/20/26 | ||
| Low | 177.09 on 12/24/24 | 93.63 on 04/24/26 | 26.63 on 04/27/26 | ||
| High | 187.42 on 12/31/24 | 98.19 on 04/22/26 | 28.23 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | -14.09% since 11/29/24 | +7.29% since 03/27/26 | +4.12% since 03/27/26 | ||
| Low | 170.99 on 12/19/24 | 90.08 on 03/30/26 | 25.76 on 03/30/26 | ||
| High | 216.73 on 12/02/24 | 99.92 on 04/15/26 | 29.43 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -17.73% since 09/30/24 | -6.37% since 01/27/26 | -21.85% since 01/27/26 | ||
| Low | 170.99 on 12/19/24 | 89.25 on 03/24/26 | 24.95 on 03/20/26 | ||
| High | 248.16 on 10/04/24 | 109.48 on 02/09/26 | 33.52 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +29.47% since 06/28/24 | +4.08% since 10/27/25 | -7.39% since 10/27/25 | ||
| Low | 142.00 on 07/08/24 | 84.02 on 10/28/25 | 24.95 on 03/20/26 | ||
| High | 248.16 on 10/04/24 | 112.29 on 01/07/26 | 35.43 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,031,018 | 18,836,676 | 17,264,164 | ||
| Shares Outstanding, K | 97,618 | 199,014 | 642,507 | ||
| Annual Sales | 2,458,780,000 | 5,141,240,000 | 3,720,000,000 | ||
| Annual Net Income | -881,710,000 | 1,286,650,000 | 963,000,000 | ||
| Last Quarter Sales | 1,001,600,000 | 1,506,840,000 | 1,058,000,000 | ||
| Last Quarter Net Income | -121,350,000 | 299,280,000 | 31,000,000 | ||
| 60-Month Beta | 0.57 | 0.85 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 11/12/24 | 1.80 on 02/10/26 | 0.05 on 02/17/26 | ||
| Latest Earnings Date | 02/24/25 | 04/28/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.49 | 17.41 | ||